等待开盘 07-07 09:30:00 美东时间
-4.810
-2.21%
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
59分钟前
Jefferies analyst Fahad Tariq maintains Franco-Nevada (NYSE:FNV) with a Hold and lowers the price target from $258 to $245.
07-06 23:25
今日重点评级关注:Oppenheimer:维持Protara Therapeutics"跑赢大市"评级,目标价从25美元升至28美元;Piper Sandler:维持Bright Minds Biosciences"超配"评级,目标价从190美元升至220美元
05-21 12:05
TD Cowen analyst Derick Ma upgrades Franco-Nevada (NYSE:FNV) from Hold to Buy and lowers the price target from $292 to $291.
05-21 00:54
Franco-Nevada Corporation (($TSE:FNV)) has held its Q1 earnings call. Read on f...
05-20 09:50
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
黄金权益金巨头Franco-Nevada Corporation周三宣布,将向股东支付2026年第二季度每股0.44美元的现金股息,与此前季度派息水平保持一...
05-13 23:02
Franco-Nevada (FNV) declares $0.44/share quarterly dividend, in line with previous. Forward yield 0.74% Payable June 25; for shareholders of record June 11; ex-div June 11. See FNV Dividend Scorecard,...
05-13 21:28